4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole, 95.0%, 25g

(8-methylimidazo[1,2-a]pyridin-3-yl)methanol, 95.0%, 2g

6-Chloro-1H-indole-2-carbaldehyde, 95.0%, 10g

(2-Methyl-3-furyl)methanol, 97.0%, 5g

N-(5-Bromothiazol-2-yl) acetamide hydrobromide, 95.0%, 10g

6-Chloropyrido[3,4-d]pyrimidin-4-amine, 98%, 1g

N,N-dimethyl-1-[4-(2-pyrrolidinyl)phenyl]methanamine dihydrochloride hydrate, 95.0%, 1g

Methyl 4'-bromomethyl-biphenyl-2-carboxylate, 95.0%, 5g

4-Amino-2-chloro-5-methylpyrimidine, 95.0%, 1g

Methyl 2-(4-ethynylphenyl)acetate, 97%, 5g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 25 m, Ø-Innen 0,20 mm, Filmd. 0,10 µm, 1 Stück

1-(2-Methyl(8-quinolyloxy))-2-nitro-4-(trifluoromethyl)benzene, 95.0%, 5g

(R)-Oxetan-2-ylmethanol, 97%, 250mg